Nk. Worrall et al., INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE AMELIORATES FUNCTIONAL AND HISTOLOGICAL-CHANGES OF ACUTE LUNG ALLOGRAFT-REJECTION, Transplantation, 63(8), 1997, pp. 1095-1101
Background. We recently demonstrated that inhibition of inducible nitr
ic oxide synthase (iNOS) ameliorated severe acute lung allograft rejec
tion, This study used a rat lung transplant model to determine (1) the
time course and cellular localization of iNOS expression during the h
istological progression of unmodified acute rejection and (2) whether
inhibition of iNOS prevented impaired gas exchange function of the all
ograft lung and/or ameliorated the histological changes of acute rejec
tion. Methods and Results. iNOS mRNA and enzyme activity were expresse
d in allograft lungs during mild, moderate, and severe acute rejection
, but not in normal, isograft, or allograft lungs before histological
changes of mild acute rejection, iNOS expression in allografts resulte
d in elevated serum nitrite/nitrate levels, indicative of increased in
vivo nitric oxide (NO) production, In situ hybridization demonstrated
iNOS mRNA expression in infiltrating inflammatory cells, but not in a
llograft parenchymal cells, Allografts had significantly impaired gas
exchange, which was prevented with the selective iNOS inhibitor aminog
uanidine (PaO2 of 566+/-19, 76+/-22, and 504+/-105 mmHg for isograft,
allograft, and aminoguanidine-treated allograft, respectively; P<0.000
2). Aminoguanidine also significantly improved the histological reject
ion scores. Conclusions. (1) iNOS expression and increased NO producti
on occurred during the early stages of acute rejection, persisted thro
ughout the unmodified rejection process, and localized to infiltrating
inflammatory cells, but not allograft parenchymal cells; (2) aminogua
nidine ameliorated the histological and functional changes of acute re
jection; and (3) increased NO production, detected by the presence of
iNOS mRNA, protein, or noninvasively by measuring serum nitrite/nitrat
e levels, may serve as an early marker of acute allograft rejection.